Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
Chong
A S
AS
Department of General Surgery, Rush Presbyterian-St Luke's Medical Center, Chicago, Illinois 60612, USA.
Shen
J
J
Xiao
F
F
Blinder
L
L
Foster
P
P
Sankary
H
H
Williams
J W
JW
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D006224:Cricetinae; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D008647:Mesocricetus; D051381:Rats; D011917:Rats, Inbred Lew; D014183:Transplantation, Heterologous / Q000276:immunology*; D016042:Transplantation, Heterotopic
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D016572:Cyclosporine; D000077339:Leflunomide